Remission of infantile generalized myofibromatosis after interferon alpha therapy

被引:13
作者
Auriti, Cinzia [1 ]
Kieran, Mark W. [5 ]
Deb, Giovanni [3 ]
Devito, Rita [4 ]
Pasquini, Luciano [2 ]
Danhaive, Olivier [1 ]
机构
[1] Bambino Gesu Pediat Hosp, Dept Neonatol, I-00165 Rome, Italy
[2] Bambino Gesu Pediat Hosp, Dept Cardiol, I-00165 Rome, Italy
[3] Bambino Gesu Pediat Hosp, Div Oncol, I-00165 Rome, Italy
[4] Bambino Gesu Pediat Hosp, Div Pathol, I-00165 Rome, Italy
[5] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Pediat Oncol, Boston, MA 02115 USA
关键词
angiogenesis; vascular endothelial growth factor; basic fibroblast growth factor; visceral myofibroma; interferon alpha-2b;
D O I
10.1097/MPH.0b013e31815e62bb
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Infantile myofibromatosis is the most common fibrous tumor of infancy. Solitary or generalized myofibromas without visceral involvement usually regress within a few months. The multifocal disease infantile generalized myofibromatosis, with visceral involvement, is associated with a significant mortality due to the effect of tumors on vital organs. We report a case of infantile generalized myofibromatosis with visceral involvement, including 2 right atrium tumors. The infant expressed high circulating vascular endothelial growth factor and fibroblast growth factor-2 levels, and interferon alpha-2b was started as antiangiogenic treatment, aimed at triggering regression of the life-threatening cardiac lesions. The tumors regressed and vascular endothelial growth factor and fibroblast growth factor-2 levels were reduced after treatment discontinuation.
引用
收藏
页码:179 / 181
页数:3
相关论文
共 27 条
[1]   Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy [J].
Barlow, CF ;
Priebe, CJ ;
Mulliken, JB ;
Barnes, PD ;
Mac Donald, D ;
Folkman, J ;
Ezekowitz, RAB .
JOURNAL OF PEDIATRICS, 1998, 132 (03) :527-530
[2]   Serum vascular endothelial growth factor in pediatric patients with community-acquired pneumonia and pleural effusion [J].
Choi, Seong Hwan ;
Park, Eun Young ;
Jung, Hye Lim ;
Shim, Jae Won ;
Kim, Deok Soo ;
Park, Moon Soo ;
Shim, Jung Yeon .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2006, 21 (04) :608-613
[3]   CONGENITAL GENERALIZED MYOFIBROMATOSIS - A DISSEMINATED ANGIOCENTRIC MYOFIBROMATOSIS [J].
COFFIN, CM ;
NEILSON, KA ;
INGELS, S ;
FRANKGERSZBERG, R ;
DEHNER, LP .
PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 1995, 15 (04) :571-587
[4]   Successful therapy of a patient with infantile generalized myofibromatosis [J].
Day, M ;
Edwards, AO ;
Weinberg, A ;
Leavey, PJ .
MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 38 (05) :371-373
[5]   Endocardial location of familial myofibromatosis revealed by cerebral embolization:: cardiac counterpart of the frequent intravascular growth of the disease? [J].
de Montpréville, VT ;
Zemoura, L ;
Vaksmann, G ;
Lecourt-Tierny, G ;
Planché, C ;
Dulmet, E .
VIRCHOWS ARCHIV, 2004, 444 (03) :300-303
[6]   Spastic diplegia and interferon [J].
Deb, G ;
Jenkner, A ;
Donfrancesco, A .
JOURNAL OF PEDIATRICS, 1999, 134 (03) :382-382
[7]  
Deb G, 1997, MED PEDIATR ONCOL, V28, P358, DOI 10.1002/(SICI)1096-911X(199705)28:5<358::AID-MPO6>3.3.CO
[8]  
2-6
[9]   Toxicity profile of interferon alfa-2b in children:: A prospective evaluation [J].
Dubois, J ;
Hershon, L ;
Carmant, L ;
Bélanger, S ;
Leclerc, JM ;
David, M .
JOURNAL OF PEDIATRICS, 1999, 135 (06) :782-785
[10]  
EZEKOWITZ RA, 1995, NEW ENGL J MED, V333, P556